Asset Publisher

How Salmonella tackles cellular defense mechanisms

Researchers uncover new protein that plays key role in bacterial infections

RI-MUHC researcher receives funding from the CFI and Government of Quebec

Congratulations to Erwin Schurr for his new grant from the Canada Foundation for Innovation’s (CFI) John R. Evans Leaders Fund.

Move to single-patient rooms at MUHC’s Glen site resulted in immediate, dramatic and long-lasting decrease of infection rates

Rates of colonization of two health-associated infections tumbled soon after historic hospital move

All programs on board in 2019 for RI-MUHC Summer Student Research Day

Congratulations to students who contributed to the scientific life of our institute this summer!

Montréal sans HépC: a fight to eliminate HCV in Montreal

Marina Klein co-leads initiative to make Montreal the first city in North America to eliminate hepatitis C

Two awards for a Canadian postdoc at meeting that sets the gold standard of HIV science

RI-MUHC trainee Stéphane Isnard honoured for his research on gut permeability in HIV

Multiple honours for Dr. Évelyne Vinet

RI-MUHC researcher earns distinctions from the European League Against Rheumatism, Laurentian Conference of Rheumatology and McGill University

Five RI-MUHC members named CRC Chairs

Congratulations to five members of the Research Institute of the McGill University Health Centre (RI-MUHC)

Dr. Donald Sheppard appointed Chair of the Department of Microbiology and Immunology

Dr. Donald Sheppard has been appointed to the position of Chair of the Department of Microbiology and Immunology in the Faculty of Medicine, McGill University, as of July 1.

MI4 unveils first round of Seed Fund Grants

Interdisciplinary and multi-institutional projects aim to tackle infectious and immune threats to human health 

The Centre for Outcomes Research and Evaluation’s third Annual Research Day was a success!

The May 14 event organized by the Centre for Outcomes Research and Evaluation (CORE) provided an opportunity for trainees from all eight RI-MUHC programs to share their work and discoveries.

Recognizing great ideas at the McGill Clinical Innovation Competition

Congratulations to two winning teams from the RI-MUHC: BetaSense and Antibiotic Sentinel!

Guidelines for managing anaphylaxis in children need an update

New study shows that pre-hospital treatment with epinephrine has the highest protective effect against uncontrolled allergic reaction

Dr. Donald Sheppard honoured at the McGill Alumni Association’s annual Honours and Awards banquet

The David Johnston Faculty & Staff Award recognizes his leadership in research efforts to tackle grand challenges in infections and immunity

Widespread off-label use of epilepsy medications could put some patients at risk

Despite limited proven efficacy, gabapentinoids are frequently prescribed to treat pain

Drug-Resistant TB: A Clear and Present Danger

In two articles posted this week to Forbes, Dr. Madhukar Pai outlines the great threat posed by drug-resistant tuberculosis (DR-TB), while also offering a glimmer of hope.

Research Day for the IDIGH Program at the RI-MUHC is organized for and by trainees ... but everyone profits!

Nine awards were given across three presentation categories at the Fourth Annual Research Day of the Infectious Diseases and Immunity in Global Health Program

RI-MUHC researcher to receive new funding from GlycoNet

Dr. Don Sheppard`s project in collaboration with The Hospital for Sick Children aims to improve the health of Canadians while generating positive economic outcomes

Talking open science with Dr. Nitika Pant Pai

Dr. Nitika Pant Pai answers questions about her work with ScienceOpen and how it can benefit researchers and, ultimately, patients

Four Burning Questions for Madhukar Pai and Dick Menzies on World TB Day

Leading researchers at the McGill International TB Centre and RI-MUHC discuss the conditions that allow TB to flourish and the important role McGill and the RI-MUHC are playing to combat it.

See Archive - IDIGH